Radhakrishnan Ramchandren Selected Research

Radhakrishnan Ramchandren Research Topics

Disease

22	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 06/2012
9	Neoplasms (Cancer) 01/2021 - 12/2013
5	Disease Progression 02/2023 - 10/2013
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 01/2019
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021 - 10/2013
4	Neutropenia 01/2021 - 01/2018
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2017 - 06/2012
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 01/2020
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 03/2014
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2020 - 12/2014
2	Febrile Neutropenia 01/2022 - 01/2018
2	Pneumonia (Pneumonitis) 01/2021 - 02/2019
2	Lymphoma (Lymphomas) 01/2020 - 06/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 03/2014 - 08/2013
1	Amyloidosis 11/2023
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Nausea 12/2021
1	Hepatitis 01/2020
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2020
1	Chemical and Drug Induced Liver Injury 01/2020
1	Anemia 10/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2019
1	Exanthema (Rash) 10/2019
1	Acute Kidney Injury (Acute Renal Failure) 02/2019
1	Sepsis (Septicemia) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2009

Drug/Important Bio-Agent (IBA)

18	Brentuximab VedotinIBA 01/2022 - 06/2012
6	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 08/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2018
5	Rituximab (Mabthera)FDA Link 02/2023 - 01/2018
5	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2018
5	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 01/2018
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2018
4	ibrutinibIBA 02/2023 - 01/2019
4	Lenalidomide (CC 5013)FDA Link 02/2023 - 10/2013
4	NivolumabIBA 12/2021 - 01/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2022 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 10/2019
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 10/2019
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 02/2019
2	Ifosfamide FDA LinkGeneric 01/2020 - 01/2019
2	LigandsIBA 10/2018 - 01/2018
1	Amyloid (Amyloid Fibrils)IBA 11/2023
1	Prealbumin (Transthyretin)IBA 11/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023
1	Iodine-124IBA 11/2023
1	Peptides (Polypeptides)IBA 11/2023
1	venetoclaxIBA 10/2021
1	fimepinostatIBA 10/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	durvalumabIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	PlatinumIBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	tributyl phosphate (TBP)IBA 01/2020
1	urelumabIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	Aurora Kinase AIBA 10/2019
1	MLN 8237IBA 10/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Aspartic Acid (Aspartate)FDA Link 01/2019
1	itacitinibIBA 01/2019
1	parsaclisibIBA 01/2019
1	Janus Kinase 1IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 10/2018
1	Inotuzumab OzogamicinIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Bortezomib (Velcade)FDA Link 10/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2009
1	Dasatinib (BMS 354825)FDA Link 01/2009

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2009
9	Stem Cell Transplantation 02/2023 - 06/2012
9	Drug Therapy (Chemotherapy) 06/2021 - 01/2018
3	Salvage Therapy 12/2021 - 01/2018
1	Intravenous Infusions 11/2023
1	Transplantation 01/2022
1	Homologous Transplantation 01/2021
1	Nephrectomy 02/2019
1	Cell Transplantation 10/2018
1	Intravenous Administration 01/2016
1	Retreatment 03/2014